Mark L. Levitt
Directeur Technique/Scientifique/R&D chez REDHILL BIOPHARMA LTD.
Profil
Mark L.
Levitt is currently the Director at EnGeneIC Pty Ltd.
and the Chief Scientific Officer at RedHill Biopharma Ltd.
He previously worked as the Director at UPMC Cancer Institute and as the Head-Lung Cancer Unit at Sheba Medical Center.
Postes actifs de Mark L. Levitt
Sociétés | Poste | Début |
---|---|---|
REDHILL BIOPHARMA LTD. | Directeur Technique/Scientifique/R&D | 01/01/2022 |
EnGeneIC Pty Ltd.
EnGeneIC Pty Ltd. BiotechnologyHealth Technology EnGeneIC Pty Ltd. develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer. It offers targeted drug delivery, gene silencing, canine cancers and principal characteristics technology solutions. The company was founded by Jennifer A. MacDiarmid and Himanshu Brahmbhatt in 2001 and is headquartered in Sydney, Australia. | Directeur/Membre du Conseil | - |
Anciens postes connus de Mark L. Levitt
Sociétés | Poste | Fin |
---|---|---|
UPMC Cancer Institute
UPMC Cancer Institute Medical/Nursing ServicesHealth Services UPMC Cancer Institute provides health care and insurance services. The company was founded in 1985 and is headquartered in Pittsburgh, PA. | Directeur/Membre du Conseil | - |
Sheba Medical Center
Sheba Medical Center Hospital/Nursing ManagementHealth Services Sheba Medical Center is a hospital engaging in medical science and biotechnical innovation. Its services include emergency room services, cancer treatment, psychiatry, and hematological examination. The company was founded on June 21, 1948 and is headquartered in Ramat Gan, Israel. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
REDHILL BIOPHARMA LTD. | Health Technology |
Entreprise privées | 3 |
---|---|
EnGeneIC Pty Ltd.
EnGeneIC Pty Ltd. BiotechnologyHealth Technology EnGeneIC Pty Ltd. develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer. It offers targeted drug delivery, gene silencing, canine cancers and principal characteristics technology solutions. The company was founded by Jennifer A. MacDiarmid and Himanshu Brahmbhatt in 2001 and is headquartered in Sydney, Australia. | Health Technology |
Sheba Medical Center
Sheba Medical Center Hospital/Nursing ManagementHealth Services Sheba Medical Center is a hospital engaging in medical science and biotechnical innovation. Its services include emergency room services, cancer treatment, psychiatry, and hematological examination. The company was founded on June 21, 1948 and is headquartered in Ramat Gan, Israel. | Health Services |
UPMC Cancer Institute
UPMC Cancer Institute Medical/Nursing ServicesHealth Services UPMC Cancer Institute provides health care and insurance services. The company was founded in 1985 and is headquartered in Pittsburgh, PA. | Health Services |